An Observational Study of IgA Nephropathy: Pathological Variants and Clinical Data
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01502579 |
Recruitment Status
:
Completed
First Posted
: December 30, 2011
Last Update Posted
: August 28, 2013
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
IgA Nephropathy |
Study Type : | Observational |
Actual Enrollment : | 603 participants |
Time Perspective: | Prospective |
Official Title: | An Observational Study of the Relationship Between Pathological Variants and Clinical Data at Presentation and Follow-up in IgA Nephropathy |
Study Start Date : | September 2011 |
Actual Primary Completion Date : | August 2013 |
Actual Study Completion Date : | August 2013 |

- glomerular filtration rate decline or end-stage renal disease or doubling of serum creatinine [ Time Frame: after the biopsy ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 80 Years (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- biopsy-proven IgA nephropathy;
Exclusion Criteria:

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01502579
China, Guangdong | |
Guangdong General Hospital | |
Guangzhou, Guangdong, China, 510080 |
Principal Investigator: | Wei Shi, MD,PhD | Guangdong General Hospital |
Responsible Party: | Wei Shi, Professor, Guangdong General Hospital |
ClinicalTrials.gov Identifier: | NCT01502579 History of Changes |
Other Study ID Numbers: |
GGH201106 |
First Posted: | December 30, 2011 Key Record Dates |
Last Update Posted: | August 28, 2013 |
Last Verified: | August 2013 |
Keywords provided by Wei Shi, Guangdong General Hospital:
IgA nephropathy |
Additional relevant MeSH terms:
Kidney Diseases Glomerulonephritis, IGA Urologic Diseases Glomerulonephritis |
Nephritis Autoimmune Diseases Immune System Diseases |